In a groundbreaking development in the field of human tissue engineering, researchers at Rambam Eye Institute in Haifa, Israel, have successfully transplanted a 3D-printed cornea to a legally blind patient, marking the first time such a procedure has been accomplished. This innovative surgery took place at the end of October and was conducted in collaboration with Precise Bio, a company specializing in regenerative technology.
The 3D-printed cornea was developed using living human corneal cells cultivated in a lab, rather than relying on traditional donor tissue. This advancement could significantly alleviate the global shortage of corneal transplants, potentially benefiting millions who suffer from corneal blindness due to injuries, infections, or genetic disorders.
Corneal transplant surgeries generally have a high success rate of around 97% in developed countries like the U.S.; however, in regions lacking eye banks and efficient tissue distribution systems, patients might experience lengthy waits for suitable donor tissue. Remarkably, the technology used for this specific cornea allowed for the creation of approximately 300 implants from a single healthy donor cornea, facilitating a scalable solution for those in need.
The concept of 3D-printed corneas originally gained traction back in 2018 at Newcastle University in the UK. The advance by Precise Bio represents nearly a decade of refinement, involving collaborations with clinicians to bring this innovative approach to fruition.
Moreover, Precise Bio has indicated that their technology has the potential to extend beyond corneal applications to include the printing of cardiac, liver, and kidney tissues, which could address transplant shortages for these vital organs. However, the technology will require extensive validation and trials before it can be widely applied.
For more information on the technology and the procedure, you can visit the Rambam Health Care Campus and Precise Bio.